Ribosomal protein S20 pseudogene 13 (RPS20P13)

**Ribosomal protein S20 pseudogene 13 (RPS20P13)** is a processed pseudogene in the human genome, derived from the parental RPS20 gene encoding a ribosomal protein of the 40S subunit[1][3][4][6]. Pseudogenes like RPS20P13 generally do not produce functional proteins and are considered "disabled" genetic copies due to mutations such as premature stop codons or frameshifts that abrogate standard gene expression[1][6]. RPS20P13, specifically, is classified as a retrocopy—originating from reverse transcription and chromosomal integration of RPS20 mRNA, which is a common mechanism for ribosomal protein pseudogenes in the human genome[4][6]. RPS20P13 *is not a therapeutic target* and *does not encode a functional protein*[1][6]. There is no reported biological activity, disease association, drug interaction, or established biomarker value for this pseudogene[1][3][4]. Thus, it is not relevant for therapeutic or diagnostic applications. If the intention is to refer to an active ribosomal protein, the correct target would be "Ribosomal protein S20 (RPS20)." **Summary of issues:** - RPS20P13 is a pseudogene, not a functional protein or valid therapeutic target[1][3][6]. - No biological function, molecular interaction, or disease relevance is established for this entry[1][3][6]. - Use of this name as a drug or biomarker target is incorrect[1][3][4]. **Note:** For biological activity or roles in disease, refer to the original parental gene RPS20[7].

Other names

RPS20_5_284